Aug 13, 2020
Targeted Transcriptome Analysis Uncovers Previously Unknown Isoform Reprograming in Colon Cancer
Aug 12, 2020
Australian Therapeutic Goods Administration Approves the First Phase I Trial of ATG-017 for the Treatment of Patients with Advanced Solid Tumors and Hematological Malignancies
Jun 17, 2020
Lexogen and OnRamp Bioinformatics partner to provide differential gene expression data analysis and interpretation for QuantSeq 3' mRNA-Seq users
Jun 17, 2020
Sirnaomics and Precision NanoSystems Have Formed a Partnership
Jun 10, 2020
Sao Thai Duong JSC launches RT-LAMP KIT to Meet Demands for the Widening of Testing After Easing of Lockdown
Jun 10, 2020
Infrawear Obtains FDA IV.D Status Alongside Exclusive Deal with Genesprint for Worldwide Distribution of PCR Swab and NCOV-19 IGM/ IGG Antibody Test Kits for COVID-19
Jun 09, 2020
Lexogen Launches the TraPR Kit for Isolation of Functional Small RNAs
Jun 02, 2020
The Global Protein Assays Market is expected to grow from USD 1,723.11 Million in 2018 to USD 3,812.13 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 12.01%
Jun 02, 2020
Moleculin Announces Emory University Clinical Trial of WP1066 Begins Enrollment
May 21, 2020
Nephron, One Medical Partner to Offer COVID-19 Testing Services
May 14, 2020
CoreMedica Providing COVID-19 Antibody Testing for Hotspot Mitigation
May 01, 2020
Two Georgia Companies Unite to Provide Coronavirus (COVID-19) Testing
Apr 29, 2020
Lexogen Receives FFG Funding to Develop a Novel SARS-CoV-2 Test for Mass Screening
Apr 28, 2020
Caris Life Sciences Submits Two PMA Applications to the FDA for Whole Exome and Whole Transcriptome Sequencing
Apr 27, 2020
ERBA Mannheim Launches CE Marked COVID-19 Antibody ELISA Kits - FDA EUA Following Soon
Apr 21, 2020
The Real Time RT-PCR Technique Plays a Key Role in Early Detection in Treating Covid-19 Patients
Apr 17, 2020
Igenomix launches COVID-19 RT-PCR Test and introduces a new Biological Passport for a COVID-19 free society
Apr 13, 2020
CNS Pharmaceuticals Announces Independent University Research Confirms Active Compound in WP1122 Completely Prevents Coronavirus Replication In Vitro; WP1122 is Subject to Development Agreement with WPD Pharmaceuticals
Apr 02, 2020
NanoMosaic Announces Exclusive License to Nanoneedle Technology from Harvard
Mar 30, 2020
Delphi Genetics More Than Triples Its Production Capacity and Receives GMP Certification